Home › Lupus › Tennessee › Jackson
Lupus clinical trials in Jackson, TN
5 studies for Lupus are looking for participants at sites in and around Jackson (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
RecruitingPhase 3
- West Tennessee Research Institute, Jackson
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
RecruitingPhase 2
- West Tennessee Research Institute, Jackson
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
RecruitingPhase 3
- West Tennessee Research Institute, Jackson
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
RecruitingPhase 1
- West Tennessee Research Institute - Jackson /ID# 284561, Jackson
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
RecruitingPhase 3
- Sl0044 50001, Jackson
About Lupus
Lupus is an autoimmune disease that causes your immune system to attack your healthy tissues and cells. This can cause damage to many parts of your body.
More about Lupus on MedlinePlus
Lupus trials in other cities
- New York City, NY18 studies
- Houston, TX13 studies
- Durham, NC12 studies
- Miami, FL10 studies
- Washington, DC10 studies
- Tampa, FL9 studies
- Philadelphia, PA9 studies
- Clearwater, FL8 studies
- Chicago, IL8 studies
- Boston, MA8 studies
- Santa Monica, CA8 studies
- Los Angeles, CA8 studies
Other studies in Jackson
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.